Literature DB >> 8185635

Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily.

D L Rimm1, J S Morrow.   

Abstract

The gene encoding full-length human E-cadherin has been cloned and sequenced from liver and colon cDNA libraries (GenBank Accession #L08599). The predicted molecular mass of the unglycosylated and unprocessed protein is 97,000. The human protein conserves most features of the classical cadherins. In its cytoplasmic domain, two approximately 30-35 aminoacid conserved sequence motifs are recognized. These cadherin homology domains have been termed "CH2" and "CH3", and are characteristic of the classical cadherins, but absent or divergent in the more distantly related cadherins such as desmosomal cadherin, T-cadherin, fat, and the human ret oncogene. Given these findings and the importance of cytoplasmic interactions to cadherin function, a subclassification of the cadherin superfamily based on cytoplasmic domain homologies is proposed. This subclassification provides a framework in future studies for understanding the distinct down-stream signaling cascades associated with each cadherin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185635     DOI: 10.1006/bbrc.1994.1656

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains.

Authors:  A Tomschy; C Fauser; R Landwehr; J Engel
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

2.  Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism.

Authors:  Parimal Sheth; Ankur Seth; Katherine J Atkinson; Tarun Gheyi; Gautam Kale; Francesco Giorgianni; Dominic M Desiderio; Chunying Li; Anjaparavanda Naren; Radhakrishna Rao
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

Review 3.  Adhesion or anti-adhesion in cancer: what matters more?

Authors:  S Jothy; S B Munro; L LeDuy; D McClure; O W Blaschuk
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 4.  Phospho-regulation of Beta-catenin adhesion and signaling functions.

Authors:  Rebecca Leadem Daugherty; Cara J Gottardi
Journal:  Physiology (Bethesda)       Date:  2007-10

5.  Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.

Authors:  D L Rimm; E R Koslov; P Kebriaei; C D Cianci; J S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Rap1 regulates the formation of E-cadherin-based cell-cell contacts.

Authors:  Catherine Hogan; Norberto Serpente; Patricia Cogram; Catherine Rose Hosking; Carl Uli Bialucha; Stephan Michael Feller; Vania M M Braga; Walter Birchmeier; Yasuyuki Fujita
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Casein kinase 1 is a novel negative regulator of E-cadherin-based cell-cell contacts.

Authors:  Sophie Dupre-Crochet; Angélica Figueroa; Catherine Hogan; Emma C Ferber; Carl Uli Bialucha; Joanna Adams; Emily C N Richardson; Yasuyuki Fujita
Journal:  Mol Cell Biol       Date:  2007-03-12       Impact factor: 4.272

8.  Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin.

Authors:  J M Higgins; D A Mandlebrot; S K Shaw; G J Russell; E A Murphy; Y T Chen; W J Nelson; C M Parker; M B Brenner
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

9.  Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.

Authors:  Hideyuki Ishiguro; Takehiro Wakasugi; Yukio Terashita; Nobuhiro Sakamoto; Tatsuya Tanaka; Koji Mizoguchi; Hiroyuki Sagawa; Tomotaka Okubo; Hiromitsu Takeyama
Journal:  World J Surg Oncol       Date:  2016-09-06       Impact factor: 2.754

Review 10.  The use of coiled-coil proteins in drug delivery systems.

Authors:  Ainsley A McFarlane; George L Orriss; Jörg Stetefeld
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.